Abstract
The present invention relates to radiolabeled organic compounds. More particularly, the present invention relates to radiolabeled monoacylglycerol lipase (MAGL) inhibitors that are useful for medical imaging, such as positron-emission tomography (PET), single-photon emission computed tomography (SPECT) and/or autoradiography.
| Original language | English |
|---|---|
| Patent number | WO2021/048241 A1 |
| IPC | C07D 498/04,C07B 59/00,A61P 25/16,A61P 25/28,A61P 35/00,A61K 31/5365 |
| Priority date | 12/09/19 |
| Filing date | 10/09/20 |
| Publication status | Published - 18 Mar 2021 |
Keywords
- Positron-Emission Tomography
- MAGL
- Radionuclides